Crenessity (crinecerfont) — United Healthcare

Initial criteria

• Diagnosis of classic congenital adrenal hyperplasia (CAH)
• age ≥ 4 years
• Patient will receive concomitant glucocorticoid replacement (e.g., dexamethasone, hydrocortisone, methylprednisolone, prednisone, prednisolone)

Reauthorization criteria

• Documentation of positive clinical response to Crenessity therapy
• Patient will continue to receive concomitant glucocorticoid replacement (e.g., dexamethasone, hydrocortisone, methylprednisolone, prednisone, prednisolone)

Approval duration

12 months